Medical - Healthcare Information Services
Compare Stocks
5 / 10Stock Comparison
PINC vs HCA vs THC vs CYH vs MCK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
Medical - Distribution
PINC vs HCA vs THC vs CYH vs MCK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Distribution |
| Market Cap | $2.34B | $95.95B | $17.01B | $408M | $92.15B |
| Revenue (TTM) | $1.00B | $75.60B | $21.45B | $21.48B | $403.43B |
| Net Income (TTM) | $-24M | $6.78B | $1.70B | $-88M | $4.76B |
| Gross Margin | 72.6% | 41.5% | 42.8% | 53.7% | 3.6% |
| Operating Margin | -0.0% | 15.8% | 16.1% | -39.8% | 1.5% |
| Forward P/E | 20.8x | 14.2x | 10.9x | 0.8x | 19.3x |
| Total Debt | $282M | $50.20B | $13.17B | $11.58B | $7.39B |
| Cash & Equiv. | $84M | $1.04B | $2.88B | $260M | $5.69B |
PINC vs HCA vs THC vs CYH vs MCK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Nov 25 | Return |
|---|---|---|---|
| Premier, Inc. (PINC) | 100 | 81.2 | -18.8% |
| HCA Healthcare, Inc. (HCA) | 100 | 430.0 | +330.0% |
| Tenet Healthcare Co… (THC) | 100 | 948.9 | +848.9% |
| Community Health Sy… (CYH) | 100 | 123.2 | +23.2% |
| McKesson Corporation (MCK) | 100 | 511.3 | +411.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PINC vs HCA vs THC vs CYH vs MCK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PINC ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.07, yield 3.0%
- Lower volatility, beta 0.07, Low D/E 18.4%, current ratio 0.64x
- Beta 0.07, yield 3.0%, current ratio 0.64x
- 3.0% yield, 1-year raise streak, vs MCK's 0.4%, (2 stocks pay no dividend)
HCA has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- 9.0% margin vs PINC's -2.4%
- 11.3% ROA vs PINC's -0.8%, ROIC 19.9% vs 0.0%
THC is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 5.2% 10Y total return vs MCK's 348.1%
- PEG 0.33 vs HCA's 0.67
- +27.4% vs CYH's -11.7%
CYH is the clearest fit if your priority is value.
- Lower P/E (0.8x vs 19.3x)
MCK is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
- 16.2% revenue growth vs PINC's -10.9%
- Beta 0.04 vs CYH's 1.60
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.2% revenue growth vs PINC's -10.9% | |
| Value | Lower P/E (0.8x vs 19.3x) | |
| Quality / Margins | 9.0% margin vs PINC's -2.4% | |
| Stability / Safety | Beta 0.04 vs CYH's 1.60 | |
| Dividends | 3.0% yield, 1-year raise streak, vs MCK's 0.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +27.4% vs CYH's -11.7% | |
| Efficiency (ROA) | 11.3% ROA vs PINC's -0.8%, ROIC 19.9% vs 0.0% |
PINC vs HCA vs THC vs CYH vs MCK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PINC vs HCA vs THC vs CYH vs MCK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MCK leads in 1 of 6 categories
THC leads 1 • PINC leads 0 • HCA leads 0 • CYH leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — PINC and THC each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MCK is the larger business by revenue, generating $403.4B annually — 402.2x PINC's $1.0B. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to PINC's -2.4%. On growth, CYH holds the edge at +2.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $75.6B | $21.5B | $21.5B | $403.4B |
| EBITDAEarnings before interest/tax | $118M | $15.5B | $4.3B | -$7.8B | $6.8B |
| Net IncomeAfter-tax profit | -$24M | $6.8B | $1.7B | -$88M | $4.8B |
| Free Cash FlowCash after capex | $265M | $7.7B | $3.3B | -$200M | $6.0B |
| Gross MarginGross profit ÷ Revenue | +72.6% | +41.5% | +42.8% | +53.7% | +3.6% |
| Operating MarginEBIT ÷ Revenue | -0.0% | +15.8% | +16.1% | -39.8% | +1.5% |
| Net MarginNet income ÷ Revenue | -2.4% | +9.0% | +7.9% | -0.4% | +1.2% |
| FCF MarginFCF ÷ Revenue | +26.4% | +10.2% | +15.6% | -0.9% | +1.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.3% | +6.7% | +2.8% | +2.8% | +6.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -70.0% | +44.6% | +87.6% | -45.2% | +37.0% |
Valuation Metrics
Evenly matched — THC and CYH each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 0.8x trailing earnings, CYH trades at a 99% valuation discount to PINC's 128.5x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.38x vs MCK's 0.75x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.3B | $95.9B | $17.0B | $408M | $92.1B |
| Enterprise ValueMkt cap + debt − cash | $2.5B | $145.1B | $27.3B | $11.7B | $93.8B |
| Trailing P/EPrice ÷ TTM EPS | 128.45x | 15.12x | 12.53x | 0.77x | 29.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.79x | 14.19x | 10.94x | — | 19.28x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.72x | 0.38x | — | 0.75x |
| EV / EBITDAEnterprise value multiple | 21.35x | 9.37x | 6.34x | — | 18.74x |
| Price / SalesMarket cap ÷ Revenue | 2.31x | 1.27x | 0.80x | 0.03x | 0.26x |
| Price / BookPrice ÷ Book value/share | 1.70x | — | 1.97x | — | — |
| Price / FCFMarket cap ÷ FCF | 7.33x | 12.47x | 6.72x | 1.96x | 17.63x |
Profitability & Efficiency
MCK leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-2 for PINC. PINC carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to THC's 1.47x. On the Piotroski fundamental quality scale (0–9), HCA scores 7/9 vs PINC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -1.6% | — | +19.6% | — | +3.0% |
| ROA (TTM)Return on assets | -0.8% | +11.3% | +5.7% | -0.7% | +5.7% |
| ROICReturn on invested capital | +0.0% | +19.9% | +13.2% | -70.1% | +5.4% |
| ROCEReturn on capital employed | +0.0% | +27.0% | +13.8% | -87.3% | +30.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 7 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.18x | — | 1.47x | — | — |
| Net DebtTotal debt minus cash | $198M | $49.2B | $10.3B | $11.3B | $1.7B |
| Cash & Equiv.Liquid assets | $84M | $1.0B | $2.9B | $260M | $5.7B |
| Total DebtShort + long-term debt | $282M | $50.2B | $13.2B | $11.6B | $7.4B |
| Interest CoverageEBIT ÷ Interest expense | 1.13x | 5.37x | 4.28x | 4.89x | 33.79x |
Total Returns (Dividends Reinvested)
THC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $1,902 for CYH. Over the past 12 months, THC leads with a +27.4% total return vs CYH's -11.7%. The 3-year compound annual growth rate (CAGR) favors THC at 40.7% vs CYH's -6.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | — | -8.6% | -2.7% | -6.6% | -8.5% |
| 1-Year ReturnPast 12 months | +24.0% | +19.7% | +27.4% | -11.7% | +4.6% |
| 3-Year ReturnCumulative with dividends | +14.8% | +57.4% | +178.5% | -16.8% | +106.4% |
| 5-Year ReturnCumulative with dividends | -9.2% | +109.7% | +190.4% | -81.0% | +286.9% |
| 10-Year ReturnCumulative with dividends | -4.6% | +450.5% | +523.4% | -80.3% | +348.1% |
| CAGR (3Y)Annualised 3-year return | +4.7% | +16.3% | +40.7% | -6.0% | +27.3% |
Risk & Volatility
Evenly matched — PINC and MCK each lead in 1 of 2 comparable metrics.
Risk & Volatility
MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINC currently trades 98.2% from its 52-week high vs CYH's 64.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.07x | 0.29x | 0.71x | 1.60x | 0.04x |
| 52-Week HighHighest price in past year | $28.79 | $556.52 | $247.21 | $4.47 | $999.00 |
| 52-Week LowLowest price in past year | $20.62 | $330.00 | $146.60 | $2.38 | $637.00 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +77.1% | +78.5% | +64.8% | +75.3% |
| RSI (14)Momentum oscillator 0–100 | 65.0 | 30.8 | 52.9 | 46.4 | 16.2 |
| Avg Volume (50D)Average daily shares traded | 0 | 1000K | 1.2M | 1.6M | 757K |
Analyst Outlook
Evenly matched — PINC and MCK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PINC as "Hold", HCA as "Buy", THC as "Buy", CYH as "Hold", MCK as "Buy". Consensus price targets imply 38.1% upside for THC (target: $268) vs -0.0% for PINC (target: $28). For income investors, PINC offers the higher dividend yield at 2.98% vs MCK's 0.36%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $28.25 | $527.45 | $268.00 | $2.93 | $1006.50 |
| # AnalystsCovering analysts | 31 | 46 | 32 | 37 | 31 |
| Dividend YieldAnnual dividend ÷ price | +3.0% | +0.7% | — | — | +0.4% |
| Dividend StreakConsecutive years of raises | 1 | 5 | 0 | 2 | 17 |
| Dividend / ShareAnnual DPS | $0.84 | $2.94 | — | — | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +17.1% | +10.5% | +8.4% | +0.5% | +3.4% |
MCK leads in 1 of 6 categories (Profitability & Efficiency). THC leads in 1 (Total Returns). 4 tied.
PINC vs HCA vs THC vs CYH vs MCK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PINC or HCA or THC or CYH or MCK a better buy right now?
For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.
2% revenue growth year-over-year, versus -10. 9% for Premier, Inc. (PINC). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate HCA Healthcare, Inc. (HCA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PINC or HCA or THC or CYH or MCK?
On trailing P/E, Community Health Systems, Inc.
(CYH) is the cheapest at 0. 8x versus Premier, Inc. at 128. 5x. On forward P/E, Tenet Healthcare Corporation is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 33x versus HCA Healthcare, Inc. 's 0. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PINC or HCA or THC or CYH or MCK?
Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.
9%, compared to -81. 0% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: THC returned +523. 4% versus CYH's -80. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PINC or HCA or THC or CYH or MCK?
By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.
04β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 3618% more volatile than MCK relative to the S&P 500. On balance sheet safety, Premier, Inc. (PINC) carries a lower debt/equity ratio of 18% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — PINC or HCA or THC or CYH or MCK?
By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.
2% versus -10. 9% for Premier, Inc. (PINC). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to -78. 8% for Premier, Inc.. Over a 3-year CAGR, MCK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PINC or HCA or THC or CYH or MCK?
HCA Healthcare, Inc.
(HCA) is the more profitable company, earning 9. 0% net margin versus 0. 9% for McKesson Corporation — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus -79. 4% for CYH. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PINC or HCA or THC or CYH or MCK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 33x versus HCA Healthcare, Inc. 's 0. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Tenet Healthcare Corporation (THC) trades at 10. 9x forward P/E versus 20. 8x for Premier, Inc. — 9. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THC: 38. 1% to $268. 00.
08Which pays a better dividend — PINC or HCA or THC or CYH or MCK?
In this comparison, PINC (3.
0% yield), HCA (0. 7% yield), MCK (0. 4% yield) pay a dividend. THC, CYH do not pay a meaningful dividend and should not be held primarily for income.
09Is PINC or HCA or THC or CYH or MCK better for a retirement portfolio?
For long-horizon retirement investors, HCA Healthcare, Inc.
(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +450. 5% 10Y return). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCA: +450. 5%, CYH: -80. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PINC and HCA and THC and CYH and MCK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PINC is a small-cap quality compounder stock; HCA is a mid-cap deep-value stock; THC is a mid-cap deep-value stock; CYH is a small-cap deep-value stock; MCK is a mid-cap high-growth stock. PINC, HCA pay a dividend while THC, CYH, MCK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.